How many insider trades does FilingIQ track for MIST?

FilingIQ tracks 106 Form 4 insider transactions for MIST (Milestone Pharmaceuticals Inc.), covering filings from May 8, 2019 onwards. 1 of those were filed in the last 90 days.

Are MIST insiders net buyers or net sellers?

Across the full Form 4 history for MIST, 25 transactions (24%) were open-market purchases and 17 (16%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MIST insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MIST in?

Milestone Pharmaceuticals Inc. (MIST) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $144.79M.

MIST insider trading

NasdaqGS Healthcare

Milestone Pharmaceuticals Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

106

Last 90 days

Buys / sells

24% / 16%

Market cap

$144.79M

About Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Company website: www.milestonepharma.com

MIST insider activity at a glance

FilingIQ has scored 106 insider transactions for MIST since May 8, 2019. The most recent filing in our index is dated Apr 16, 2026.

Across the full history, 25 open-market purchases and 17 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MIST insider trades is 50.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MIST trades on FilingIQ Raw filings on SEC EDGAR

Latest MIST Form 4 filings

Oliveto Joseph President and CEO

S Dec 15, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding MIST

VR Adviser, LLC

$22.29M · 3.4% of AUM

Frequently asked

How many insider trades does FilingIQ track for MIST?: FilingIQ tracks 106 Form 4 insider transactions for MIST (Milestone Pharmaceuticals Inc.), covering filings from May 8, 2019 onwards. 1 of those were filed in the last 90 days.
Are MIST insiders net buyers or net sellers?: Across the full Form 4 history for MIST, 25 transactions (24%) were open-market purchases and 17 (16%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MIST insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MIST in?: Milestone Pharmaceuticals Inc. (MIST) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $144.79M.

Methodology & sources

Every MIST insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.